222 related articles for article (PubMed ID: 37566146)
1. siRNA-Based Novel Therapeutic Strategies to Improve Effectiveness of Antivirals: An Insight.
Chatterjee K; Lakdawala S; Quadir SS; Puri D; Mishra DK; Joshi G; Sharma S; Choudhary D
AAPS PharmSciTech; 2023 Aug; 24(6):170. PubMed ID: 37566146
[TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges.
Kang H; Ga YJ; Kim SH; Cho YH; Kim JW; Kim C; Yeh JY
J Biomed Sci; 2023 Oct; 30(1):88. PubMed ID: 37845731
[TBL] [Abstract][Full Text] [Related]
3. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
4. Synthetic SiRNA Delivery: Progress and Prospects.
Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS
Methods Mol Biol; 2016; 1364():291-310. PubMed ID: 26472459
[TBL] [Abstract][Full Text] [Related]
5. RNAi-based drug discovery and its application to therapeutics.
Hokaiwado N; Takeshita F; Banas A; Ochiya T
IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962
[TBL] [Abstract][Full Text] [Related]
6. siRNAs and Viruses: The good, the Bad and the Way Forward.
Soobramoney C; Parboosing R
Curr Mol Pharmacol; 2022; 15(1):143-158. PubMed ID: 33881977
[TBL] [Abstract][Full Text] [Related]
7. Journey of siRNA: Clinical Developments and Targeted Delivery.
Nikam RR; Gore KR
Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
[TBL] [Abstract][Full Text] [Related]
8. RNA interference strategies as therapy for respiratory viral infections.
DeVincenzo JP
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S118-22. PubMed ID: 18820571
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach.
Mahmoodi Chalbatani G; Dana H; Gharagouzloo E; Grijalvo S; Eritja R; Logsdon CD; Memari F; Miri SR; Rad MR; Marmari V
Int J Nanomedicine; 2019; 14():3111-3128. PubMed ID: 31118626
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.
Draz MS; Fang BA; Zhang P; Hu Z; Gu S; Weng KC; Gray JW; Chen FF
Theranostics; 2014; 4(9):872-92. PubMed ID: 25057313
[TBL] [Abstract][Full Text] [Related]
11. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
DeVincenzo JP
Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.
Miele E; Spinelli GP; Miele E; Di Fabrizio E; Ferretti E; Tomao S; Gulino A
Int J Nanomedicine; 2012; 7():3637-57. PubMed ID: 22915840
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic face of RNAi: in vivo challenges.
Borna H; Imani S; Iman M; Azimzadeh Jamalkandi S
Expert Opin Biol Ther; 2015 Feb; 15(2):269-85. PubMed ID: 25399911
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanoparticles for short interfering RNA delivery.
Leung AK; Tam YY; Cullis PR
Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
[TBL] [Abstract][Full Text] [Related]
15. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
Sivakumar P; Kim S; Kang HC; Shim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
[TBL] [Abstract][Full Text] [Related]
16. siRNA delivery systems for cancer treatment.
Oh YK; Park TG
Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
[TBL] [Abstract][Full Text] [Related]
17. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
18. Development of RNAi technology for targeted therapy--a track of siRNA based agents to RNAi therapeutics.
Zhou Y; Zhang C; Liang W
J Control Release; 2014 Nov; 193():270-81. PubMed ID: 24816071
[TBL] [Abstract][Full Text] [Related]
19. Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use.
Parashar D; Rajendran V; Shukla R; Sistla R
Eur J Pharm Sci; 2020 Jan; 142():105159. PubMed ID: 31747618
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-mediated delivery of small RNA molecules in tumor therapy.
Aigner A; Fischer D
Pharmazie; 2016 Jan; 71(1):27-34. PubMed ID: 26867350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
